Attached files
file | filename |
---|---|
10-Q - Shengtai Pharmaceutical, Inc. | v202576_10q.htm |
EX-31.1 - Shengtai Pharmaceutical, Inc. | v202576_ex31-1.htm |
EX-31.2 - Shengtai Pharmaceutical, Inc. | v202576_ex31-2.htm |
EX-32.1 - Shengtai Pharmaceutical, Inc. | v202576_ex32-1.htm |
Exhibit
32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of Shengtai Pharmaceutical, Inc., the
“Company,” on Form 10-Q for the quarter ended September 30, 2010, as filed with
the Securities and Exchange Commission on the date hereof, the “Report,” I, Hu
Ye, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:
|
(1)
|
The Report fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and
|
|
The information contained in the
Report fairly presents, in all material respects, the financial condition
and results of operations of the
Company.
|
Date:
November 16, 2010
|
/s/ Hu Ye
|
Hu
Ye
|
|
Title:
Chief Financial Officer
|
|
(Principal
Financial Officer)
|